Pricing Log in Create free account

Absci Corporation (ABSI) vs Maze Therapeutics, Inc. (MAZE)

Absci Corporation and Maze Therapeutics, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. is the larger, with a market value of $2.0B against $1.7B — 1.2× the size. Maze Therapeutics, Inc. has the higher net margin (0.00% vs −7,756.4%) and the higher return on invested capital (−112.4% vs −174.7%). Across the 13 metrics below, Maze Therapeutics, Inc. leads on 10 and Absci Corporation on 3.

Valuation

Metric ABSI MAZE Biotechnology median
P/E n/m n/m 10.96
P/S 1,004.75 n/m 9.52
P/B 6.37 4.62 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 876.04 n/m 9.00
Earnings yield (8.03%) (7.09%) (32.09%)
Free cash flow yield (6.94%) (5.10%) (22.62%)

Profitability

Metric ABSI MAZE Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (8,084.50%) 0.00% 0.00%
Net margin (7,756.37%) 0.00% 0.00%
Free cash flow margin (6,969.83%) 0.00% 0.00%
Return on equity (57.72%) (37.35%) (50.12%)
Return on assets (50.57%) (31.99%) (45.12%)
Return on invested capital (174.74%) (112.36%) 0.00%

Growth

Metric ABSI MAZE Biotechnology median
Revenue growth (TTM) (62.28%) — 6.78%
EPS growth (last fiscal year) 10.64% (344.00%) 29.88%
Revenue growth, 5-year CAGR (10.14%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABSI MAZE Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 10.63 18.31 4.74
Net debt to EBITDA 1.32 2.43 1.01

Dividend

Metric ABSI MAZE Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ABSI MAZE Biotechnology median
Market cap 1.71b 1.97b 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack